000			06171nam a22004813i 4500
001			EBC351012
003			MiAaPQ
005			20181121151323.0
006			m o d |
007			cr cnu||||||||
008			181113s2006 xx o ||||0 eng d
020			_a9780470750285 _q(electronic bk.)
020			_z9781405133777
035			_a(MiAaPQ)EBC351012
035			_a(Au-PeEL)EBL351012
035			_a(CaPaEBR)ebr10232980
035			_a(CaONFJC)MIL132207
035			_a(OCoLC)437214018
040			_aMiAaPQ _beng _erda _epn _cMiAaPQ _dMiAaPQ
050		4	_aRC862.I53C553 2006
082	0		_a616.344
100	1		_aIrving, Peter.
245	1	0	_aClinical Dilemmas in Inflammatory Bowel Disease.
250			_a1st ed.
264		1	_aChichester : _bJohn Wiley & Sons, Incorporated, _c2006.
264		4	_c©2008.
300			_a1 online resource (264 pages)
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
505	0		_aIntro -- Clinical Dilemmas in: Inflammatory Bowel Disease -- Contents -- List of Contributors -- Preface -- Part 1 Investigating IBD in the 21st Century -- 1 Capsule endoscopy: do we need it? -- 2 Pathology reports - pitfalls for the unwary -- 3 Non-invasive diagnosis and assessment -- 4 What is the best way to image perianal Crohn's disease? -- 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome -- 6 Abnormal liver tests - what should we do about them? -- Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs -- 5-ASA drugs -- 7 Is monitoring necessary? -- 8 Do they have a role in Crohn's disease? -- Steroids -- 9 Steroids in Crohn's: are they obsolete? -- Antibiotics for Crohn's disease -- 10 Antibiotics: which, when, and for how long? -- 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator? -- Immunomodulators -- 12 TPMT testing: is it essential? -- 13 6-Mercaptopurine or azathioprine? -- 14 Thiopurines: how long should we use them for? -- 15 Making the most of methotrexate -- 16 Cyclosporine: balancing risk and benefit -- Infliximab -- 17 Contraindications - absolute or relative? -- 18 How can we prevent tuberculosis? -- 19 Dealing with infusion reactions -- 20 Use in ulcerative colitis -- 21 Infliximab and surgery: health or hazard? -- Nutritional therapy for Crohn's disease -- 22 Nutritional therapy for Crohn's disease: is it for adults? -- Part 3 Medical Treatment: What's Round the Corner? -- 23 Trials and tribulations - interpreting clinical trials in IBD -- 24 Genetics - clinical and therapeutic applications -- 25 Probiotics - separating science from snakeoil -- 26 Worms -- 27 Smoking and nicotine - poison for Crohn's, potion for colitis? -- 28 Heparin -- 29 Leukocytapheresis: filtering out the facts -- 30 Appendectomy for ulcerative colitis - a therapeutic option?.
505	8		_a31 Biologic treatments in IBD -- 32 Stem cell transplantation for IBD -- 33 Complementary and alternative therapy - the way forward or a step back? -- Part 4 Common Clinical Challenges: Beyond the Text Book -- 34 Functional problems -- 35 Psychological stress: something to worry about? -- 36 Drugs to avoid -- 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD? -- 38 Iron replacement - is it safe and effective? -- 39 Hepatitis B and C viruses - how do they affect management of IBD? -- 40 Pregnancy: what drugs can we use? -- 41 How to prevent growth failure in children -- 42 Predicting outcome in severe UC -- 43 Refractory proctitis -- 44 CMV co-infection - does it matter? -- 45 Treatment of oral Crohn's disease -- 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease -- 47 Short bowel -- 48 Management of internal fistulae -- 49 What is indeterminate colitis? -- 50 Pouches for indeterminate colitis? -- 51 Colitis-associated cancer: what's the risk to your patients? -- 52 What to do with dysplasia, DALMs, and adenomas -- Part 5 Managing IBD Outside the Gut -- 53 Pyoderma gangrenosum -- 54 Arthritides - helping the joints without harming the gut -- 55 Prevention and treatment of osteoporosis -- 56 Sclerosing cholangitis - what to do? -- 57 Thromboembolic disease: an under-recognized complication? -- 58 Pulmonary manifestations: rare but real -- Part 6 Are You Sure it's IBD? -- 59 Intestinal infections: mimics and precipitants of relapse -- 60 Microscopic colitis -- 61 Diverticular colitis -- Part 7 The IBD Service: Time for a Rethink? -- 62 Outpatient services - do doctors still have a role? -- 63 Shared care: tactical team selection -- 64 Databases - are they worth the bother? -- Index.
520			_aEvidence-based guidance to answer more than 60 controversial clinical questions on inflammatory bowel disease Clinical Dilemmas in Inflammatory Bowel Disease is a practical handbook providing quick but detailed answers to the questions and challenges that you are faced with daily in the clinical setting. Each short chapter addresses a different topic and provides evidence-based guidance on subjects ranging from optimising current management through to special management problems and novel treatments. This book is suitable for all medical professionals involved in the care of patients with IBD: established and trainee gastroenterologists, colorectal surgeons, pathologists, radiologists, specialist nurses, pharmacists, dieticians and counsellors.
588			_aDescription based on publisher supplied metadata and other sources.
590			_aElectronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2018. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650		0	_aInflammatory bowel diseases -- Decision making.
650		0	_aInflammatory bowel diseases.
655		4	_aElectronic books.
700	1		_aRampton, David.
700	1		_aShanahan, Fergus.
776	0	8	_iPrint version: _aIrving, Peter _tClinical Dilemmas in Inflammatory Bowel Disease _dChichester : John Wiley & Sons, Incorporated,c2006 _z9781405133777
797	2		_aProQuest (Firm)
856	4	0	_uhttps://ebookcentral.proquest.com/lib/buse-ebooks/detail.action?docID=351012 _zClick to View
999			_c59315 _d59315